Home Health News Hemophilia B Gene Therapy Sustains Efficacy Over a Decade Later By News Health 2 months Ago Share on FacebookShare on Twitter (MedPage Today) — A single infusion of adeno-associated virus (AAV)-mediated gene therapy led to sustained clinical benefit and no late-onset safety concerns in patients with severe hemophilia B, a longitudinal study showed. At a median follow… Source link : https://www.medpagetoday.com/hematologyoncology/hemophilia/116033 Author : Publish date : 2025-06-12 15:19:00 Copyright for syndicated content belongs to the linked Source. Categories: Health News Related Content Vaccine Expert: My Grandchild Has Autism, but Vaccines Aren't to Blame By News Health July 31, 2025 Vaping Declined in States With Flavor Bans -- But It's Not All Good News By News Health July 31, 2025 Hospital Refuses to Disable Death Row Inmate's ICD; Dentist Gets Life Sentence By News Health July 31, 2025 Ousted Vaccine Panel Members Say Rigorous Science Is Being Abandoned By News Health July 31, 2025 Trump Overrules RFK Jr.; Giant Earthquake During Cancer Surgery; Ground Beef Recall By News Health July 31, 2025 Critics of de-extinction research hit by mystery smear campaign By News Health July 31, 2025